Clinical trial
Safety and Efficacy of Lemborexant for Patients With Cirrhosis and Sleep Problems: a Randomized Clinical Trial
NCT07480096 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Lemborexant for Patients With Cirrhosis and Sleep Problems: a Randomized Clinical Trial
- Lead sponsor
- Indonesia University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 1, 2024
- Completion date
- October 30, 2025
- Enrollment
- 82 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis, hepatic encephalopathy, insomnia, liver cirrhosis, sleep quality